Get the Stockscreener App
14.53
4.08%
+0.57
After Hours:
14.63
0.10
+0.69%
Scholar Rock Holding Corp stock is currently priced at $14.53, with a 24-hour trading volume of 495.32K.
It has seen a +4.08% increased in the last 24 hours and a -3.13% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $13.91 pivot point. If it approaches the $14.79 resistance level, significant changes may occur.
Previous Close:
$13.96
Open:
$14.05
24h Volume:
495.32K
Market Cap:
$1.13B
Revenue:
$47.30M
Net Income/Loss:
$-165.79M
P/E Ratio:
-7.3756
EPS:
-1.97
Net Cash Flow:
$-145.30M
1W Performance:
+4.91%
1M Performance:
-3.13%
6M Performance:
+36.95%
1Y Performance:
+102.37%
1D Range:
$13.88
$14.71
52W Range:
$5.56
$21.17
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
620 Memorial Drive, 2nd Floor, Cambridge, MA
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Wall Street Breakfast: The Week Ahead
Seeking Alpha
FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week
Seeking Alpha
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst
Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Benzinga
Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move This High?
Zacks Investment Research
Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK)
Zacks Investment Research
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Scholar Rock Holding Corp (SRRK) Revenue 2024
SRRK reported a revenue (TTM) of $47.30 million for the quarter ending March 31, 2022.
Scholar Rock Holding Corp (SRRK) Net Income 2024
SRRK net income (TTM) was -$165.79 million for the quarter ending December 31, 2023, a -23.26% decrease year-over-year.
Scholar Rock Holding Corp (SRRK) Cash Flow 2024
SRRK recorded a free cash flow (TTM) of -$145.30 million for the quarter ending December 31, 2023, a -8.63% decrease year-over-year.
Scholar Rock Holding Corp (SRRK) Earnings per Share 2024
SRRK earnings per share (TTM) was -$1.99 for the quarter ending December 31, 2023, a +12.72% growth year-over-year.
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of various medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company is developing its lead antibody product candidate, SRK-015, a first-in-class inhibitor of the activation of myostatin that is in clinical development stage for the treatment of spinal muscular atrophy. It is also developing various product candidates for a range of serious diseases, including other neuromuscular disorders, cancer, fibrosis, and anemia. The company was founded in 2012 and is based in Cambridge, Massachusetts.
1.53%
3.38%
Cap:
|
Volume (24h):